{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T21:57:37Z","timestamp":1789509457452,"version":"build-2803163510"},"reference-count":66,"publisher":"Springer Science and Business Media LLC","issue":"S1","license":[{"start":{"date-parts":[[2024,10,12]],"date-time":"2024-10-12T00:00:00Z","timestamp":1728691200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,10,12]],"date-time":"2024-10-12T00:00:00Z","timestamp":1728691200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Alma Mater Studiorum - Universit\u00e0 di Bologna"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Endocrinol Invest"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Purpose<\/jats:title>\n            <jats:p>Adrenal incidentalomas (AIs) and pituitary incidentalomas (PIs) have become frequent findings in the last two decades due to the widespread use of cross-sectional imaging in clinical practice. This review investigates the prevalence of endogenous hypercortisolism in patients with AIs and PIs. We aim to underscore the importance of early detection and management of endogenous hypercortisolism in this subset of patients to mitigate associated cardiometabolic complications and reduce mortality.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>We performed a PubMed literature search to provide updates regarding the prevalence of endogenous hypercortisolism in patients with AIs and PIs, the demographic and clinical characteristics of the studied populations, and the diagnostic test accuracy for early identification of endogenous hypercortisolism.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Hypercortisolism, especially mild autonomous cortisol secretion (MACS), was identified in a notable proportion of patients with AIs. MACS was associated with increased cardiometabolic risks, contributing to an elevated overall mortality rate in this cohort. Furthermore, PIs were found to be linked with Cushing\u2019s disease in a subset of patients, emphasizing the need for thorough evaluation and monitoring.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>Early diagnosis and appropriate management of endogenous hypercortisolism are essential in preventing complications and improving patient outcomes. As the presence of undetected hypercortisolism is associated with clinical complications over time, the accurate identification of high-risk populations to screen remains crucial.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1007\/s40618-024-02456-6","type":"journal-article","created":{"date-parts":[[2024,10,12]],"date-time":"2024-10-12T07:01:54Z","timestamp":1728716514000},"page":"63-71","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Who and how to screen for endogenous hypercortisolism in adrenal and pituitary incidentaloma"],"prefix":"10.1007","volume":"48","author":[{"given":"Kimberly","family":"Coscia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"Verrienti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1291-8906","authenticated-orcid":false,"given":"Guido","family":"Di Dalmazi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Chiara","family":"Zatelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,10,12]]},"reference":[{"key":"2456_CR1","doi-asserted-by":"publisher","DOI":"10.1093\/ejendo\/lvad066","author":"M Fassnacht","year":"2023","unstructured":"Fassnacht M et al (2023) Management of adrenal incidentalomas: European Society of Endocrinology Clinical Practice Guideline in collaboration with the European Network for the study of adrenal tumors. Eur J Endocrinol. https:\/\/doi.org\/10.1093\/ejendo\/lvad066","journal-title":"Eur J Endocrinol"},{"issue":"16","key":"2456_CR2","doi-asserted-by":"publisher","first-page":"1542","DOI":"10.1056\/NEJMcp2031112","volume":"384","author":"K Electron","year":"2021","unstructured":"Electron K (2021) Adrenal incidentaloma. N Engl J Med 384(16):1542\u20131551. https:\/\/doi.org\/10.1056\/NEJMcp2031112","journal-title":"N Engl J Med"},{"issue":"11","key":"2456_CR3","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1016\/S2213-8587(20)30314-4","volume":"8","author":"A Ebbehoj","year":"2020","unstructured":"Ebbehoj A et al (2020) Epidemiology of adrenal tumours in Olmsted County, Minnesota, USA: a population-based cohort study. Lancet Diabetes Endocrinol 8(11):894\u2013902. https:\/\/doi.org\/10.1016\/S2213-8587(20)30314-4","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"6","key":"2456_CR4","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1210\/endrev\/bnaa008","volume":"41","author":"M Sherlock","year":"2020","unstructured":"Sherlock M et al (2020) Adrenal incidentaloma. Endocr Rev 41(6):775\u2013820. https:\/\/doi.org\/10.1210\/endrev\/bnaa008","journal-title":"Endocr Rev"},{"key":"2456_CR5","doi-asserted-by":"publisher","unstructured":"Okroj D, Rzepecka A, K\u0142osowski P, Babi\u0144ska A, Sworczak K (2023) Review of diagnostic modalities for adrenal incidentaloma. J Clin Med 12(11). https:\/\/doi.org\/10.3390\/jcm12113739","DOI":"10.3390\/jcm12113739"},{"issue":"11","key":"2456_CR6","doi-asserted-by":"publisher","first-page":"3331","DOI":"10.1210\/clinem\/dgab512","volume":"106","author":"I Bancos","year":"2021","unstructured":"Bancos I, Prete A (2021) Approach to the patient with adrenal incidentaloma. J Clin Endocrinol Metab 106(11):3331\u20133353. https:\/\/doi.org\/10.1210\/clinem\/dgab512","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"2456_CR7","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1016\/S0022-3468(97)90649-7","volume":"32","author":"SK Mayer","year":"1997","unstructured":"Mayer SK, Oligny LL, Deal C, Yazbeck S, Gagn\u00e9 IN, Blanchard H (1997) Childhood adrenocortical tumors: Case series and reevaluation of prognosis - A 24-year experience. J Pediatr Surg 32(6):911\u2013915. https:\/\/doi.org\/10.1016\/S0022-3468(97)90649-7","journal-title":"J Pediatr Surg"},{"issue":"6","key":"2456_CR8","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1530\/EJE-10-1147","volume":"164","author":"M Terzolo","year":"2011","unstructured":"Terzolo M et al (2011) AME position statement on adrenal incidentaloma. Eur J Endocrinol 164(6):851\u2013870. https:\/\/doi.org\/10.1530\/EJE-10-1147","journal-title":"Eur J Endocrinol"},{"issue":"2","key":"2456_CR9","doi-asserted-by":"publisher","first-page":"R57","DOI":"10.1530\/EJE-18-0296","volume":"179","author":"I Bourdeau","year":"2018","unstructured":"Bourdeau I, Ghorayeb NE, Gagnon N, Lacroix A (2018) Differential diagnosis, investigation and therapy of bilateral adrenal incidentalomas. Eur J Endocrinol 179(2):R57\u2013R67. https:\/\/doi.org\/10.1530\/EJE-18-0296","journal-title":"Eur J Endocrinol"},{"key":"2456_CR10","doi-asserted-by":"publisher","unstructured":"de Mariani BM et al (2020) Allelic Variants of ARMC5 in Patients With Adrenal Incidentalomas and in Patients With Cushing\u2019s Syndrome Associated With Bilateral Adrenal Nodules, Front. Endocrinol. (Lausanne)., vol. 11, no. February, pp. 1\u20137, https:\/\/doi.org\/10.3389\/fendo.2020.00036","DOI":"10.3389\/fendo.2020.00036"},{"issue":"8","key":"2456_CR11","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.7326\/M20-7946","volume":"174","author":"A Kjellbom","year":"2021","unstructured":"Kjellbom A, Lindgren O, Puvaneswaralingam S, L\u00f6ndahl M, Olsen H (2021) Association between mortality and levels of autonomous cortisol secretion by adrenal incidentalomas. Ann Intern Med 174(8):1041\u20131049. https:\/\/doi.org\/10.7326\/M20-7946","journal-title":"Ann Intern Med"},{"issue":"7","key":"2456_CR12","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1016\/S2213-8587(22)00100-0","volume":"10","author":"T Deutschbein","year":"2022","unstructured":"Deutschbein T et al (2022) Age-dependent and sex-dependent disparity in mortality in patients with adrenal incidentalomas and autonomous cortisol secretion: an international, retrospective, cohort study. Lancet Diabetes Endocrinol 10(7):499\u2013508. https:\/\/doi.org\/10.1016\/S2213-8587(22)00100-0","journal-title":"Lancet Diabetes Endocrinol"},{"key":"2456_CR13","doi-asserted-by":"publisher","unstructured":"Bernardi S et al (2022) Is the adrenal incidentaloma functionally active? An Approach-To-The-patient-based review. J Clin Med 11(14). https:\/\/doi.org\/10.3390\/jcm11144064","DOI":"10.3390\/jcm11144064"},{"issue":"11","key":"2456_CR14","doi-asserted-by":"publisher","first-page":"2085","DOI":"10.1097\/HJH.0000000000003252","volume":"40","author":"F Fallo","year":"2022","unstructured":"Fallo F et al (2022) Diagnosis and management of hypertension in patients with Cushing\u2019s syndrome: a position statement and consensus of the Working Group on Endocrine Hypertension of the European Society of Hypertension. J Hypertens 40(11):2085\u20132101. https:\/\/doi.org\/10.1097\/HJH.0000000000003252","journal-title":"J Hypertens"},{"issue":"4","key":"2456_CR15","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1007\/s42000-021-00308-z","volume":"20","author":"M Araujo-Castro","year":"2021","unstructured":"Araujo-Castro M et al (2021) Accuracy of the dexamethasone suppression test for the prediction of autonomous cortisol secretion-related comorbidities in adrenal incidentalomas. Hormones 20(4):735\u2013744. https:\/\/doi.org\/10.1007\/s42000-021-00308-z","journal-title":"Hormones"},{"issue":"3","key":"2456_CR16","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1007\/s12020-017-1421-3","volume":"59","author":"F Ceccato","year":"2018","unstructured":"Ceccato F et al (2018) Daily salivary cortisol and cortisone rhythm in patients with adrenal incidentaloma. Endocrine 59(3):510\u2013519. https:\/\/doi.org\/10.1007\/s12020-017-1421-3","journal-title":"Endocrine"},{"issue":"4","key":"2456_CR17","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1111\/cen.13294","volume":"86","author":"L Papanastasiou","year":"2017","unstructured":"Papanastasiou L et al (2017) Concomitant alterations of metabolic parameters, cardiovascular risk factors and altered cortisol secretion in patients with adrenal incidentalomas during prolonged follow-up. Clin Endocrinol (Oxf) 86(4):488\u2013498. https:\/\/doi.org\/10.1111\/cen.13294","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"1","key":"2456_CR18","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1530\/eje.0.1460061","volume":"146","author":"L Barzon","year":"2002","unstructured":"Barzon L, Fallo F, Sonino N, Boscaro M (2002) Development of overt Cushing\u2019s syndrome in patients with adrenal incidentaloma. Eur J Endocrinol 146(1):61\u201366. https:\/\/doi.org\/10.1530\/eje.0.1460061","journal-title":"Eur J Endocrinol"},{"issue":"1","key":"2456_CR19","doi-asserted-by":"publisher","first-page":"94","DOI":"10.21037\/gs.2019.11.19","volume":"9","author":"A Kelsall","year":"2020","unstructured":"Kelsall A, Iqbal A, Newell-Price J (2020) Adrenal incidentaloma: Cardiovascular and metabolic effects of mild cortisol excess. Gland Surg 9(1):94\u2013104. https:\/\/doi.org\/10.21037\/gs.2019.11.19","journal-title":"Gland Surg"},{"issue":"7","key":"2456_CR20","doi-asserted-by":"publisher","first-page":"1813","DOI":"10.1210\/clinem\/dgad044","volume":"108","author":"E Sconfienza","year":"2023","unstructured":"Sconfienza E, Tetti M, Forestiero V, Veglio F, Mulatero P, Monticone S (2023) Prevalence of functioning adrenal incidentalomas: a systematic review and Meta-analysis. J Clin Endocrinol Metab 108(7):1813\u20131823. https:\/\/doi.org\/10.1210\/clinem\/dgad044","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"2456_CR21","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1530\/EJE-15-0189","volume":"173","author":"TT Agustsson","year":"2015","unstructured":"Agustsson TT et al (2015) The epidemiology of pituitary adenomas in Iceland, 1955\u20132012: a nationwide population-based study. Eur J Endocrinol 173(5):655\u2013664. https:\/\/doi.org\/10.1530\/EJE-15-0189","journal-title":"Eur J Endocrinol"},{"issue":"9","key":"2456_CR22","doi-asserted-by":"publisher","first-page":"4268","DOI":"10.1210\/jc.2010-0537","volume":"95","author":"A Raappana","year":"2010","unstructured":"Raappana A, Koivukangas J, Ebeling T, Piril\u00e4 T (2010) Incidence of pituitary adenomas in Northern Finland in 1992\u20132007. J Clin Endocrinol Metab 95(9):4268\u20134275. https:\/\/doi.org\/10.1210\/jc.2010-0537","journal-title":"J Clin Endocrinol Metab"},{"key":"2456_CR23","doi-asserted-by":"publisher","first-page":"e843","DOI":"10.1016\/j.wneu.2021.11.079","volume":"158","author":"G Watanabe","year":"2022","unstructured":"Watanabe G, Choi SY, Adamson DC (2022) Pituitary incidentalomas in the United States: A National Database Estimate. World Neurosurg 158:e843\u2013e855. https:\/\/doi.org\/10.1016\/j.wneu.2021.11.079","journal-title":"World Neurosurg"},{"key":"2456_CR24","doi-asserted-by":"publisher","unstructured":"Constantinescu SM, Maiter D (Dec. 2021) Pituitary incidentaloma. Presse Med 50(4):104081. https:\/\/doi.org\/10.1016\/j.lpm.2021.104081","DOI":"10.1016\/j.lpm.2021.104081"},{"issue":"6","key":"2456_CR25","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1007\/s11102-015-0652-7","volume":"18","author":"C Esteves","year":"2015","unstructured":"Esteves C et al (2015) Pituitary incidentalomas: analysis of a neuroradiological cohort. Pituitary 18(6):777\u2013781. https:\/\/doi.org\/10.1007\/s11102-015-0652-7","journal-title":"Pituitary"},{"key":"2456_CR26","doi-asserted-by":"publisher","unstructured":"Vasilev V et al (Oct. 2016) Pituitary \u2018incidentaloma\u2019: neuroradiological assessment and differential diagnosis. Eur J Endocrinol 175(4):R171\u2013R184. https:\/\/doi.org\/10.1530\/EJE-15-1272","DOI":"10.1530\/EJE-15-1272"},{"key":"2456_CR27","doi-asserted-by":"publisher","unstructured":"Shareef M, Nasrallah MP, AlArab N, Atweh LA, Zadeh C, Hourani R (2021) Pituitary incidentalomas in paediatric population: Incidence and characteristics., Clin. Endocrinol. (Oxf)., vol. 94, no. 2, pp. 269\u2013276, Feb. https:\/\/doi.org\/10.1111\/cen.14353","DOI":"10.1111\/cen.14353"},{"key":"2456_CR28","doi-asserted-by":"publisher","unstructured":"Thaker VV, Lage AE, Kumari G, Silvera VM, Cohen LE (2019) Clinical Course of Nonfunctional Pituitary Microadenoma in Children: A Single-Center Experience., J. Clin. Endocrinol. Metab., vol. 104, no. 12, pp. 5906\u20135912, Dec. https:\/\/doi.org\/10.1210\/jc.2019-01252","DOI":"10.1210\/jc.2019-01252"},{"key":"2456_CR29","doi-asserted-by":"publisher","unstructured":"Toini A et al (Apr. 2015) Screening for ACTH-dependent hypercortisolism in patients affected with pituitary incidentaloma. Eur J Endocrinol 172(4):363\u2013369. https:\/\/doi.org\/10.1530\/EJE-14-0599","DOI":"10.1530\/EJE-14-0599"},{"key":"2456_CR30","doi-asserted-by":"publisher","unstructured":"Ishii K et al (2019) Nov., Clinical investigation of pituitary incidentalomas: A two-center study., Intractable rare Dis. Res., vol. 8, no. 4, pp. 239\u2013244, https:\/\/doi.org\/10.5582\/irdr.2019.01083","DOI":"10.5582\/irdr.2019.01083"},{"key":"2456_CR31","doi-asserted-by":"publisher","unstructured":"Park SY et al (2017) Case report of a bilateral adrenal myelolipoma associated with Cushing disease. Med (United States) 96(52). https:\/\/doi.org\/10.1097\/MD.0000000000009455","DOI":"10.1097\/MD.0000000000009455"},{"key":"2456_CR32","doi-asserted-by":"publisher","unstructured":"Chakraborty PP, Bhattacharjee R, Mukhopadhyay P, Chowdhury S (2016) Bilateral adrenal myelolipoma in Cushing\u2019s disease: A relook into the role of corticotropin in adrenal tumourigenesis, BMJ Case Rep., vol. pp. 3\u20135, 2016, https:\/\/doi.org\/10.1136\/bcr-2016-214965","DOI":"10.1136\/bcr-2016-214965"},{"issue":"9","key":"2456_CR33","doi-asserted-by":"publisher","first-page":"E3723","DOI":"10.1210\/clinem\/dgac379","volume":"107","author":"LT Braun","year":"2022","unstructured":"Braun LT et al (2022) Whom should we screen for Cushing Syndrome? The Endocrine Society Practice Guideline recommendations 2008 Revisited. J Clin Endocrinol Metab 107(9):E3723\u2013E3730. https:\/\/doi.org\/10.1210\/clinem\/dgac379","journal-title":"J Clin Endocrinol Metab"},{"key":"2456_CR34","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1055\/a-0713-0598","volume":"127","author":"GD Dalmazi","year":"2019","unstructured":"Dalmazi GD (2019) Adrenal incidentaloma: picking out the high-risk patients. Exp Clin Endocrinol Diabetes 127:2\u20133. https:\/\/doi.org\/10.1055\/a-0713-0598","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"2456_CR35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fendo.2023.1123132","volume":"14","author":"H Remde","year":"2023","unstructured":"Remde H et al (2023) Clinical course of patients with adrenal incidentalomas and cortisol autonomy: a German retrospective single center cohort study. Front Endocrinol (Lausanne) 14:1\u201312. https:\/\/doi.org\/10.3389\/fendo.2023.1123132","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"3","key":"2456_CR36","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1097\/MED.0000000000000341","volume":"24","author":"GD Dalmazi","year":"2017","unstructured":"Dalmazi GD (2017) Update on the risks of benign adrenocortical incidentalomas. Curr Opin Endocrinol Diabetes Obes 24(3):193\u2013199. https:\/\/doi.org\/10.1097\/MED.0000000000000341","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"issue":"4","key":"2456_CR37","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1530\/EJE-11-1039","volume":"166","author":"G Di Dalmazi","year":"2012","unstructured":"Di Dalmazi G et al (2012) Progressively increased patterns of subclinical cortisol hypersecretion in adrenal incidentalomas differently predict major metabolic and cardiovascular outcomes: a large cross-sectional study. Eur J Endocrinol 166(4):669\u2013677. https:\/\/doi.org\/10.1530\/EJE-11-1039","journal-title":"Eur J Endocrinol"},{"issue":"3","key":"2456_CR38","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1097\/MED.0000000000000478","volume":"26","author":"S Athimulam","year":"2019","unstructured":"Athimulam S, Bancos I (2019) Evaluation of bone health in patients with adrenal tumors. Curr Opin Endocrinol Diabetes Obes 26(3):125\u2013132. https:\/\/doi.org\/10.1097\/MED.0000000000000478","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"2456_CR39","doi-asserted-by":"publisher","unstructured":"Zavatta G et al (2023) Apr., Mild autonomous cortisol secretion in adrenal incidentalomas and risk of fragility fractures: a large cross-sectional study, Eur. J. Endocrinol., vol. 188, no. 4, pp. 343\u2013352, https:\/\/doi.org\/10.1093\/ejendo\/lvad038","DOI":"10.1093\/ejendo\/lvad038"},{"issue":"3","key":"2456_CR40","doi-asserted-by":"publisher","first-page":"325","DOI":"10.7326\/M21-1737","volume":"175","author":"A Prete","year":"2022","unstructured":"Prete A et al (2022) Cardiometabolic Disease Burden and Steroid Excretion in Benign adrenal tumors a cross-sectional Multicenter Study. Ann Intern Med 175(3):325\u2013334. https:\/\/doi.org\/10.7326\/M21-1737","journal-title":"Ann Intern Med"},{"key":"2456_CR41","doi-asserted-by":"publisher","first-page":"747549","DOI":"10.3389\/fendo.2021.747549","volume":"12","author":"M Parasiliti-Caprino","year":"2021","unstructured":"Parasiliti-Caprino M et al (2021) A New Clinical Model to Estimate the Pre-test Probability of Cushing\u2019s syndrome: the Cushing score. Front Endocrinol (Lausanne) 12:747549. https:\/\/doi.org\/10.3389\/fendo.2021.747549","journal-title":"Front Endocrinol (Lausanne)"},{"key":"2456_CR42","doi-asserted-by":"publisher","unstructured":"Le\u00f3n-Justel A et al (Oct. 2016) A probabilistic model for Cushing\u2019s syndrome screening in At-Risk populations: a prospective Multicenter Study. J Clin Endocrinol Metab 101(10):3747\u20133754. https:\/\/doi.org\/10.1210\/jc.2016-1673","DOI":"10.1210\/jc.2016-1673"},{"key":"2456_CR43","doi-asserted-by":"publisher","unstructured":"Akirov A et al (2022) Mar., Clinical Study and Systematic Review of Pituitary Microadenomas vs. Macroadenomas in Cushing\u2019s Disease: Does Size Matter? J. Clin. Med., vol. 11, no. 6, https:\/\/doi.org\/10.3390\/jcm11061558","DOI":"10.3390\/jcm11061558"},{"issue":"8","key":"2456_CR44","doi-asserted-by":"publisher","first-page":"1581","DOI":"10.1007\/s40618-020-01484-2","volume":"44","author":"L Giovanelli","year":"2021","unstructured":"Giovanelli L et al (2021) Hidden hypercortisolism: a too frequently neglected clinical condition. J Endocrinol Invest 44(8):1581\u20131596. https:\/\/doi.org\/10.1007\/s40618-020-01484-2","journal-title":"J Endocrinol Invest"},{"issue":"12","key":"2456_CR45","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1016\/S2213-8587(21)00235-7","volume":"9","author":"M Fleseriu","year":"2021","unstructured":"Fleseriu M et al (2021) Consensus on diagnosis and management of Cushing\u2019s disease: a guideline update. Lancet Diabetes Endocrinol 9(12):847\u2013875. https:\/\/doi.org\/10.1016\/S2213-8587(21)00235-7","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"5","key":"2456_CR46","doi-asserted-by":"publisher","first-page":"1526","DOI":"10.1210\/jc.2008-0125","volume":"93","author":"LK Nieman","year":"2008","unstructured":"Nieman LK et al (2008) The diagnosis of Cushing\u2019s syndrome: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 93(5):1526\u20131540. https:\/\/doi.org\/10.1210\/jc.2008-0125","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"2456_CR47","doi-asserted-by":"publisher","first-page":"pp1105","DOI":"10.1007\/s40618-020-01197-6","volume":"43","author":"F Ceccato","year":"2020","unstructured":"Ceccato F et al (2020) Dexamethasone measurement during low-dose suppression test for suspected hypercortisolism: threshold development with and validation. J Endocrinol Invest 43(8):pp1105\u20131113. https:\/\/doi.org\/10.1007\/s40618-020-01197-6","journal-title":"J Endocrinol Invest"},{"issue":"3","key":"2456_CR48","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1007\/s40292-016-0153-4","volume":"23","author":"F Ceccato","year":"2016","unstructured":"Ceccato F, Boscaro M (2016) Cushing\u2019s syndrome: screening and diagnosis. High Blood Press Cardiovasc Prev 23(3):209\u2013215. https:\/\/doi.org\/10.1007\/s40292-016-0153-4","journal-title":"High Blood Press Cardiovasc Prev"},{"issue":"5","key":"2456_CR49","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1007\/s11102-022-01249-5","volume":"25","author":"S Petersenn","year":"2022","unstructured":"Petersenn S (2022) Overnight 1\u00a0mg dexamethasone suppression test and 24\u00a0h urine free cortisol\u2014accuracy and pitfalls when screening for Cushing\u2019s syndrome. Pituitary 25(5):693\u2013697. https:\/\/doi.org\/10.1007\/s11102-022-01249-5","journal-title":"Pituitary"},{"issue":"12","key":"2456_CR50","doi-asserted-by":"publisher","first-page":"1797","DOI":"10.1007\/s40618-020-01388-1","volume":"43","author":"F Ponzetto","year":"2020","unstructured":"Ponzetto F et al (2020) Reference ranges of late-night salivary cortisol and cortisone measured by LC\u2013MS\/MS and accuracy for the diagnosis of Cushing\u2019s syndrome. J Endocrinol Invest 43(12):1797\u20131806. https:\/\/doi.org\/10.1007\/s40618-020-01388-1","journal-title":"J Endocrinol Invest"},{"issue":"3","key":"2456_CR51","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1007\/s40618-018-0921-1","volume":"42","author":"F Ceccato","year":"2019","unstructured":"Ceccato F et al (2019) The diagnostic accuracy of increased late night salivary cortisol for Cushing\u2019s syndrome: a real-life prospective study. J Endocrinol Invest 42(3):327\u2013335. https:\/\/doi.org\/10.1007\/s40618-018-0921-1","journal-title":"J Endocrinol Invest"},{"key":"2456_CR52","doi-asserted-by":"publisher","unstructured":"Reincke M, Fleseriu M (2023) Cushing Syndrome: A Review., JAMA, vol. 330, no. 2, pp. 170\u2013181, Jul. https:\/\/doi.org\/10.1001\/jama.2023.11305","DOI":"10.1001\/jama.2023.11305"},{"issue":"10","key":"2456_CR53","doi-asserted-by":"publisher","first-page":"1947","DOI":"10.1007\/s40618-023-02099-z","volume":"46","author":"A Mondin","year":"2023","unstructured":"Mondin A et al (2023) Second-line tests in the differential diagnosis of neoplastic and non-neoplastic hypercortisolism: a systematic review and meta-analysis. J Endocrinol Invest 46(10):1947\u20131959. https:\/\/doi.org\/10.1007\/s40618-023-02099-z","journal-title":"J Endocrinol Invest"},{"key":"2456_CR54","doi-asserted-by":"publisher","unstructured":"Ceccato F, Dalmazi GD (2023) Shortage of hCRH for the diagnosis of endogenous CS: the end of an era or the beginning of a new journey? J. Endocrinol. Invest., vol. 46, no. 10, pp. 2189\u20132191, Oct. https:\/\/doi.org\/10.1007\/s40618-023-02113-4","DOI":"10.1007\/s40618-023-02113-4"},{"issue":"1","key":"2456_CR55","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1007\/bf03346701","volume":"34","author":"G Reimondo","year":"2011","unstructured":"Reimondo G et al (2011) Pros and cons of dexamethasone suppression test for screening of subclinical Cushing\u2019s syndrome in patients with adrenal incidentalomas. J Endocrinol Invest 34(1):e1\u2013e. https:\/\/doi.org\/10.1007\/bf03346701","journal-title":"J Endocrinol Invest"},{"issue":"10","key":"2456_CR56","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1530\/EC-20-0419","volume":"9","author":"G Ueland","year":"2020","unstructured":"Ueland G, Grinde T, Methlie P, Kelp O, L\u00f8v\u00e5s K, Husebye ES (2020) Diagnostic testing of autonomous cortisol secretion in adrenal incidentalomas. Endocr Connect 9(10):963\u2013970. https:\/\/doi.org\/10.1530\/EC-20-0419","journal-title":"Endocr Connect"},{"issue":"1","key":"2456_CR57","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1007\/s12020-020-02476-1","volume":"71","author":"P Falcetta","year":"2021","unstructured":"Falcetta P et al (2021) Clinical features, risk of mass enlargement, and development of endocrine hyperfunction in patients with adrenal incidentalomas: a long-term follow-up study. Endocrine 71(1):178\u2013188. https:\/\/doi.org\/10.1007\/s12020-020-02476-1","journal-title":"Endocrine"},{"issue":"3","key":"2456_CR58","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1530\/EJE-15-0036","volume":"173","author":"C Chambre","year":"2015","unstructured":"Chambre C et al (2015) The 10 Hounsfield units unenhanced computed tomography attenuation threshold does not apply to cortisol secreting adrenocortical adenomas. Eur J Endocrinol 173(3):325\u2013332. https:\/\/doi.org\/10.1530\/EJE-15-0036","journal-title":"Eur J Endocrinol"},{"issue":"4","key":"2456_CR59","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1530\/EJE-10-0962","volume":"164","author":"FP Giraldi","year":"2011","unstructured":"Giraldi FP, Saccani A, Cavagnini F (2011) Assessment of ACTH assay variability: a multicenter study. Eur J Endocrinol 164(4):505\u2013512. https:\/\/doi.org\/10.1530\/EJE-10-0962","journal-title":"Eur J Endocrinol"},{"issue":"7","key":"2456_CR60","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1007\/s40618-017-0644-8","volume":"40","author":"F Ceccato","year":"2017","unstructured":"Ceccato F et al (2017) First-line screening tests for Cushing\u2019s syndrome in patients with adrenal incidentaloma: the role of urinary free cortisol measured by LC-MS\/MS. J Endocrinol Invest 40(7):753\u2013760. https:\/\/doi.org\/10.1007\/s40618-017-0644-8","journal-title":"J Endocrinol Invest"},{"issue":"12","key":"2456_CR61","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.1007\/s40618-019-01104-8","volume":"42","author":"M Vieira-Correa","year":"2019","unstructured":"Vieira-Correa M, Giorgi RB, Oliveira KC, Hayashi LF, Costa-Barbosa FA, Kater CE (2019) Saliva versus serum cortisol to identify subclinical hypercortisolism in adrenal incidentalomas: simplicity versus accuracy. J Endocrinol Invest 42(12):1435\u20131442. https:\/\/doi.org\/10.1007\/s40618-019-01104-8","journal-title":"J Endocrinol Invest"},{"issue":"1","key":"2456_CR62","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1530\/EJE-08-0485","volume":"160","author":"B Masserini","year":"2009","unstructured":"Masserini B et al (2009) The limited role of midnight salivary cortisol levels in the diagnosis of subclinical hypercortisolism in patients with adrenal incidentaloma. Eur J Endocrinol 160(1):87\u201392. https:\/\/doi.org\/10.1530\/EJE-08-0485","journal-title":"Eur J Endocrinol"},{"key":"2456_CR63","doi-asserted-by":"publisher","unstructured":"Mohamed RS et al (2022) Late-night salivary cortisol and cortisone should be the initial screening test for Cushing\u2019s syndrome. Endocr Connect 11(7). https:\/\/doi.org\/10.1530\/EC-22-0050","DOI":"10.1530\/EC-22-0050"},{"issue":"2","key":"2456_CR64","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1210\/jc.2008-1542","volume":"94","author":"ML Nunes","year":"2009","unstructured":"Nunes ML et al (2009) Late-night salivary cortisol for diagnosis of overt and subclinical Cushing\u2019s syndrome in hospitalized and ambulatory patients. J Clin Endocrinol Metab 94(2):456\u2013462. https:\/\/doi.org\/10.1210\/jc.2008-1542","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"2456_CR65","doi-asserted-by":"publisher","first-page":"5519","DOI":"10.1210\/jc.2019-00365","volume":"104","author":"G Di Dalmazi","year":"2019","unstructured":"Di Dalmazi G et al (2019) The Steroid Profile of adrenal incidentalomas: subtyping subjects with High Cardiovascular Risk. J Clin Endocrinol Metab 104(11):5519\u20135528. https:\/\/doi.org\/10.1210\/jc.2019-00365","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"2456_CR66","doi-asserted-by":"publisher","first-page":"E1789","DOI":"10.1210\/clinem\/dgac072","volume":"107","author":"MS Liu","year":"2022","unstructured":"Liu MS et al (2022) Performance of DHEAS as a Screening Test for Autonomous Cortisol Secretion in adrenal incidentalomas: a prospective study. J Clin Endocrinol Metab 107(5):E1789\u2013E1796. https:\/\/doi.org\/10.1210\/clinem\/dgac072","journal-title":"J Clin Endocrinol Metab"}],"updated-by":[{"DOI":"10.1007\/s40618-024-02489-x","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2024,11,9]],"date-time":"2024-11-09T00:00:00Z","timestamp":1731110400000}}],"container-title":["Journal of Endocrinological Investigation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-024-02456-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40618-024-02456-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-024-02456-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,30]],"date-time":"2025-04-30T09:12:43Z","timestamp":1746004363000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40618-024-02456-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,12]]},"references-count":66,"journal-issue":{"issue":"S1","published-online":{"date-parts":[[2025,4]]}},"alternative-id":["2456"],"URL":"https:\/\/doi.org\/10.1007\/s40618-024-02456-6","relation":{},"ISSN":["1720-8386"],"issn-type":[{"value":"1720-8386","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,12]]},"assertion":[{"value":"25 September 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 August 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 October 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 November 2024","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Some part of the Funding informa\u00adtion was missing . Now they have been added.","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 November 2024","order":7,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":8,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":9,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1007\/s40618-024-02489-x","URL":"https:\/\/doi.org\/10.1007\/s40618-024-02489-x","order":10,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations\ufeff"}},{"value":"The Authors have nothing to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Statements and declarations"}}]}}